Is it possible to convert a patient's own cells into functioning insulin-producing cells as a treatment for diabetes?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Is it possible to convert a patient's own cells into functioning insulin-producing cells as a treatment for diabetes?
Released on: July 31, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    The prevalence of diabetes has been increasing at an annual rate of 5 per cent and the trend is continuing.
  • Summary
  • Transcript
  • Participants
  • Company
The prevalence of diabetes has been increasing at an annual rate of 5 per cent and the trend is continuing. An estimated 285 million people, corresponding to 6.4 per cent of the world's adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 per cent of the adult population. Vered Caplan of Orgenesis & David Kim of CureCell explain to Adrian Dawkes how they hope their collaboration will benefit sufferers of this disease.
The prevalence of diabetes has been increasing at an annual rate of 5 per cent and the trend is continuing. An estimated 285 million people, corresponding to 6.4 per cent of the world's adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 per cent of the adult population. Vered Caplan of Orgenesis & David Kim of CureCell explain to Adrian Dawkes how they hope their collaboration will benefit sufferers of this disease.
The prevalence of diabetes has been increasing at an annual rate of 5 per cent and the trend is continuing. An estimated 285 million people, corresponding to 6.4 per cent of the world's adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 per cent of the adult population. Vered Caplan of Orgenesis & David Kim of CureCell explain to Adrian Dawkes how they hope their collaboration will benefit sufferers of this disease.
The prevalence of diabetes has been increasing at an annual rate of 5 per cent and the trend is continuing. An estimated 285 million people, corresponding to 6.4 per cent of the world's adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 per cent of the adult population. Vered Caplan of Orgenesis & David Kim of CureCell explain to Adrian Dawkes how they hope their collaboration will benefit sufferers of this disease.